CardiaBase specializes in central reading of cardiac documents for clinical trials research.
CardiaBase has a single objective: to provide an ECG reading quality that exceeds regulatory compliance requirements.
CardiaBase’s experts perform continuous medical monitoring and develop interpretation solutions that will meet the forthcoming regulatory requirements.
CardiaBase brings a unique degree of specialization and a high level of cardiologic expertise.
CardiaBase is intensively committed to abide by 21 CFR Part 11 guidelines.
Alla study results can come with quality metrics (intra-reader reproducibility, inter-reader agreement, SD within).

Your study needs instantaneous teletransmission of ECGs for analysis, with turn-key site set up and no phone costs for the site? CardiaBase and Mortara have just set up the first study using ECG machine with GSM transmission (July 2006). This system is fully wireless and does not even require a telephone line on the investigation site. It’s a worldwide premiere, and it is now available at CardiaBase (for countries offering adapted GSM network). More

The technologies developed by CardiaBase make it possible to install a 100% digital cardiologic data workflow, from ECG recording on site to database export to the sponsor. Recordings are performed in investigation centers on digital devices and teletransmitted to CardiaBase’s servers via modem, GSM or Internet secured connection. The analysis is then performed on 21CFR part 11 compliant software that brings unparalleled accuracy. Results can be provided in multiple formats depending on the sponsor needs (ASCII, XML, SAS...).

Simpler, safer, and quicker: clinical studies reach a new pace.